Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis

• Published in: Brachytherapy Vol. 23; no. 2; pp. 179 - 187
• Main Authors: Watanabe, Kenta, Kamitani, Nobuhiko, Ikeda, Naoki, Kawata, Yujiro, Tokiya, Ryoji, Hayashi, Takafumi, Miyaji, Yoshiyuki, Tamada, Tsutomu, Katsui, Kuniaki
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2024
• Subjects: Adolescent; Anastomotic recurrence; Brachytherapy - methods; Child; Child, Preschool; Hematology, Oncology, and Palliative Medicine; High-dose-rate brachytherapy; Humans; Male; Neoplasm Recurrence, Local - pathology; Prostate cancer; Prostatectomy; Prostatic Neoplasms - pathology; Prostatic Neoplasms - radiotherapy; Prostatic Neoplasms - surgery; Radiology; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; BED; CSS; GI; OS; iPSA; MRI; HDR-BT; bFFF; GS; Anastomotic recurrence; Salvage therapy; GU; BCR; CT; HIFU; High-dose-rate brachytherapy; Prostate cancer; EBRT; PSA; Gleason score; genitourinary; magnetic resonance imaging; High-intensity focused ultrasound; initial prostate-specific antigen; overall survival; biochemical freedom from failure; computed tomography; cause-specific survival; biochemical recurrence; gastrointestinal; external beam radiation therapy; biological equivalent dose; prostate-specific antigen

High-dose-rate brachytherapy (HDR-BT) delivers high-dose radiation to local lesions within a short treatment period. There are no reports of salvage transurethral HDR-BT for biochemical recurrence (BCR) after radical prostatectomy. Thus, we aimed to evaluate the usefulness of salvage transurethral H...